Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000221449 | SCV000275767 | uncertain significance | Hereditary cancer-predisposing syndrome | 2024-11-21 | criteria provided, single submitter | clinical testing | The c.703_705delAAG variant (also known as p.K235del) is located in coding exon 6 of the BRIP1 gene. This variant results from an in-frame AAG deletion at nucleotide positions 703 to 705. This results in the in-frame deletion of a lysine at codon 235. The deleted amino acid position is highly conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive (Choi Y et al. PLoS ONE. 2012; 7(10):e46688). Based on the available evidence, the clinical significance of this variant remains unclear. |
Labcorp Genetics |
RCV000471922 | SCV000547319 | uncertain significance | Familial cancer of breast; Fanconi anemia complementation group J | 2024-11-13 | criteria provided, single submitter | clinical testing | This variant, c.703_705del, results in the deletion of 1 amino acid(s) of the BRIP1 protein (p.Lys235del), but otherwise preserves the integrity of the reading frame. This variant is present in population databases (no rsID available, gnomAD 0.0009%). This variant has not been reported in the literature in individuals affected with BRIP1-related conditions. ClinVar contains an entry for this variant (Variation ID: 231808). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Gene |
RCV000479679 | SCV000571922 | uncertain significance | not provided | 2023-11-05 | criteria provided, single submitter | clinical testing | In-frame deletion of 1 amino acid in a non-repeat region; Has not been previously published as pathogenic or benign to our knowledge; Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports a deleterious effect on protein structure/function |
Color Diagnostics, |
RCV000221449 | SCV000903232 | likely benign | Hereditary cancer-predisposing syndrome | 2016-07-07 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV004567577 | SCV005059266 | uncertain significance | Familial cancer of breast | 2024-02-05 | criteria provided, single submitter | clinical testing |